Japan’s Astellas to buy Iveric Bio for $5.9 billion in US biotech deal
Astellas Pharma has agreed to buy U.S. biotech group Iveric Bio for approximately $5.9 billion, marking the Japanese drugmaker’s largest-ever… Read More »Japan’s Astellas to buy Iveric Bio for $5.9 billion in US biotech deal